REG - Quadrise PLC - Business Update

QuadriseAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250818:nRSR6922Va&default-theme=true

RNS Number : 6922V  Quadrise PLC  18 August 2025

Certain of the information contained within this announcement is deemed by the
Company to constitute inside information as stipulated under The Market Abuse
Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit)
Regulations 2018. Upon the publication of this announcement via a Regulatory
Information Service ("RIS"), this inside information is now considered to be
in the public domain.

 

18 August 2025

 

Quadrise plc

("Quadrise", "QED" or the "Company")

 

Business Update

 

 

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation
of shipping and heavy industry through deployment of low emission fuels and
biofuels, is pleased to provide an update covering progress on its key
projects.

Marine

The bilateral agreements between MSC and Cargill, and Quadrise and Cargill
(the "Agreements"), remain in near final form, as announced by the Company on
10 June 2025. The Company has not received any adverse feedback from the
relevant counterparties, and their internal processes remain ongoing, albeit
slower than anticipated. On entry into the Agreements, the trial equipment
will be installed and commissioned at the MAC(2) site in Antwerp, ahead of the
commercial scale trials commencing in due course. However, the commercial
scale trials are no longer expected to commence in Q3 2025, as previously
expected, as a result of delays in entry of the Agreements.

In the meantime, the Company continues to build the marine business
development pipeline aimed at accelerating the commercialisation of
bioMSAR(TM) and MSAR®.

Americas

The trials with Sparkle Power SA in Panama have concluded to the satisfaction
of the onsite teams and the Company is now awaiting the official results from
the engine manufacturer and the client, the conclusions of which will be
announced by the Company following receipt. As previously announced, a
confirmed successful trial will enable the Company to negotiate Fuel Supply
Agreements and facilitate discussions with other regional power producers. The
trials are also an important milestone for Quadrise, being the first test for
the MSAR® and bioMSAR™ on MAN 4-stroke diesel engines, to confirm the
potential to expand product applications.

Morocco

The Company continues to await final approval from the original equipment
manufacturer ("OEM"), to progress the planned commercial trial with OCP. All
trial equipment is in place pending OEM approval.

US Low Carbon Fuels

Production growth by Valkor in Utah has progressed slower than expected during
2025, and current levels of production have been insufficient to feed the
development of mid-stream operations and marketing. Valkor expect this
situation to be resolved shortly.

Quadrise and Valkor are currently negotiating a compensation payment to the
Company for the deferral of payment of the initial licence fee due to the
Company in the amount of USD$350,000 which was originally due in January 2025.
A further update will be provided, as appropriate, in due course.

bioMSAR™ and bioMSAR™ Zero development

Quadrise continues to advance several additional joint development and
commercial discussions and testing with potential partners and customers to
seek to deliver cleaner fuels at a lower cost than alternatives.

Andy Morrison, Chair of Quadrise, commented:

"Whilst much is being done to prepare ourselves for the scale-up of our
business, it is disappointing that we have not been able to progress our
existing projects as quickly as we had expected. We remain committed to
completing these projects, to demonstrating the significant value add to our
clients that Quadrise technology can bring, and to being positioned to act
quickly as and when further opportunities arise."

 

For further information please contact:

 

 Quadrise Plc                                            +44 (0)20 7031 7321
 Andy Morrison, Chairman

 Jason Miles, Chief Technology Officer

 Nominated Adviser

 Cavendish Capital Markets Limited                       +44 (0)20 7220 0500
 Ben Jeynes
 Katy Birkin

 George Lawson

 Joint Brokers

 Shore Capital Stockbrokers Limited                      +44 (0)20 7408 4090
 Toby Gibbs, Harry Davies-Ball (Corporate Advisory)
 Fiona Conroy (Corporate Broking)

 VSA Capital Limited                                     +44 (0)20 3005 5000

 Andrew Raca (Corporate Finance)

 Andrew Monk (Corporate Broking)

 Public & Investor Relations

 Tavistock Communications (Financial PR & IR)            +44 (0) 20 7920 3150

 Simon Hudson

 Nick Elwes

 Ruairi Millar

  BLUE Communications Limited (Marine & Trade PR)

  Rhys Thomas                                            +44 (0)7595 227750

  Sam Deacon                                             +44 (0)7527 558846

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels
and biofuels, providing innovative solutions to lower energy costs, pollution
and greenhouse gas emissions today for the global power generation, shipping,
industrial and oil industries.

Learn more at: www.quadrise.com (http://www.quadrise.com/)

 

Follow us on social media:

LinkedIn: @Quadrise Plc
(https://url.avanan.click/v2/___https:/uk.linkedin.com/company/quadrise-international-ltd___.YXAxZTpzaG9yZWNhcDphOm86YzA0NmU2YmUyODVhZGE2Zjk4OWY3M2UwZmJjM2YwMWM6Njo3NjdjOjhhYzQ1NzFmN2ZlMjI3OWQ5YjBjNjBhZGEzZTkwMjlhZjUzOWIzMmE0N2EyOTlkZjQxOTlhOGM2Yjg5MDhkYTE6cDpGOk4)

X: @QuadrisePlc
(https://url.avanan.click/v2/___https:/x.com/QuadrisePlc___.YXAxZTpzaG9yZWNhcDphOm86YzA0NmU2YmUyODVhZGE2Zjk4OWY3M2UwZmJjM2YwMWM6NjphMzJiOjlkNjA5MmRmNjg2OTQxNWE4ZDFhYWIxOWRiZjk5MDAxMjc4Njg0Mjg3YjllZWEwMWQ4OTg2ZmE2ZDdiOTY1ODc6cDpGOk4)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDKZGMRKRMGKZG